+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioMarin Pharmaceutical Inc. - logo

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.

From
Enzyme Replacement Therapy - Global Strategic Business Report - Product Thumbnail Image

Enzyme Replacement Therapy - Global Strategic Business Report

  • Report
  • February 2026
  • 378 Pages
  • Global
From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
Viral Vector Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2025

  • Report
  • November 2025
  • 250 Pages
  • Global
From
Genomic Collaboration and Licensing Deals 2018-2025 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2025

  • Report
  • November 2025
  • 550 Pages
  • Global
From
From
From
From
From
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
From
From
Fabry Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Fabry Disease Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 367 Pages
  • Global
From
Hunter Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Hunter Syndrome Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 280 Pages
  • Global
From
Metabolic Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Metabolic Disorder Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 286 Pages
  • Global
From
Phenylketonuria Treatment - Global Strategic Business Report - Product Thumbnail Image

Phenylketonuria Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 184 Pages
  • Global
From
Gaucher Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gaucher Disease Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Loading Indicator